rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Todd S. Thomson

Director and 10% owner

Company insider

Files Form 4 as: Director and 10% owner, Actuate Therapeutics; Director, Cyren; Director, Cordia Bancorp; Chair/CEO Global Wealth Mgt., Citigroup.

In numbers

Trades disclosed
88
Buys
1
Sells
1
Bought
$26
Sold
$3.2M
Companies
4
Companies where not an officer
3
First trade
17 Jan 2006
Last trade
21 May 2026
Last filed
22 May 2026

Companies traded

Where they are an officer
C CitigroupOfficer · Money-centre banks · last 19 Dec 20060 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ACTU Actuate TherapeuticsDirector, 10% owner · Biotechnology · last 21 May 20260 buys · 1 sell
CyrenDirector · last 4 Jan 20210 buys · 0 sells
Cordia BancorpDirector · last 31 Aug 20161 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 22 May 2026ACTU Actuate Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
21 May 2026filed 22 May 2026ACTU Actuate Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
5 Jan 2026filed 7 Jan 2026ACTU Actuate TherapeuticsBiotechnologySEC FORM 4 Sold$1.6M280,000 at $5.80filing
5 Jan 2026filed 7 Jan 2026ACTU Actuate TherapeuticsBiotechnologySEC FORM 4 Sold$1.6M280,000 at $5.80filing
22 May 2025filed 23 May 2025ACTU Actuate Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
4 Jan 2021filed 6 Jan 2021CyrenSEC FORM 4 Code A—20,000 at $0.00filing
6 Jan 2020filed 8 Jan 2020CyrenSEC FORM 4 Code A—30,000 at $0.00filing
22 Jan 2019filed 24 Jan 2019CyrenSEC FORM 4 Code A—20,000 at $0.00filing
31 Aug 2016filed 1 Sep 2016Cordia BancorpSEC FORM 4 Code D—80,686 at $0.00filing
31 Aug 2016filed 1 Sep 2016Cordia BancorpSEC FORM 4 Code D—122,000 at $0.00filing
31 Aug 2016filed 1 Sep 2016Cordia BancorpSEC FORM 4 Code D—31,764 at $0.00filing
31 Aug 2016filed 1 Sep 2016Cordia BancorpSEC FORM 4 Code D—2,325 at $0.00filing
24 Feb 2016filed 26 Feb 2016Cordia BancorpSEC FORM 4 Code A—2,325 at $0.00filing
1 Dec 2015filed 3 Dec 2015Cordia BancorpSEC FORM 4 Code A—2,278 at $0.00filing
25 Jun 2014filed 27 Jun 2014Cordia BancorpSEC FORM 4 Code A$9,6602,300 at $4.20filing
25 Jun 2014filed 27 Jun 2014Cordia BancorpSEC FORM 4 Code C—11,764 at $0.00filing
25 Jun 2014filed 27 Jun 2014Cordia Bancorpoption or derivativeSEC FORM 4 Code C—1.18 at $0.00filing
10 Apr 2014filed 14 Apr 2014Cordia Bancorpoption or derivativeSEC FORM 4 Code P$50K1.18 at $42,500.00filing
29 Mar 2013filed 2 Apr 2013Cordia BancorpSEC FORM 4 Code J—7,507 at $0.00filing
21 Mar 2013filed 14 Apr 2014Cordia BancorpSEC FORM 4 Bought$26643 at $0.04filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Grace E. DaileyDirector · Director at Citigroup, filing Form 4 there in the last year
Gary M. ReinerDirector · Director at Citigroup, filing Form 4 there in the last year
Titilope ColeDirector · Director at Citigroup, filing Form 4 there in the last year
Casper Wilhelm von KoskullDirector · Director at Citigroup, filing Form 4 there in the last year
John Cunningham DuganDirector · Director at Citigroup, filing Form 4 there in the last year